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Main pulmonary artery diameter
from attenuation correction CT scans in cardiac
SPECT accurately predicts pulmonary
hypertension
Irene A. Burger, MD,a Lars Husmann, MD,a Bernhard A. Herzog, MD,a
Ronny R. Buechel, MD,a Aju P. Pazhenkottil, MD,a Jelena R. Ghadri, MD,a
Rene N. Nkoulou, MD,a Rolf Jenni, MD,a Erich W. Russi, MD,b and
Philipp A. Kaufmann, MDa,c,d
Objectives. To establish the value of the main pulmonary artery (MPA) diameter assessed
from unenhanced computer tomography (CT) scans used for attenuation correction (AC) of
single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) to
predict pulmonary hypertension (PHT).
Background. In contrast-enhanced chest CT scans an MPA diameter of 29 mm or greater
is an established predictor of PHT. However, it is unknown, whether measurements from an
unenhanced CT scan for AC may be used as predictor of PHT.
Methods. 100 patients underwent SPECT MPI for assessment of coronary artery disease.
PHT was defined as a right ventriculo-atrial gradient of 30 mm Hg or greater by Doppler
echocardiography. We compared MPA diameter from CT to SPECT findings (right ventricular
hypertrophy/enlargement, septal wall motion abnormality/perfusion defect, and D-shape) to
determine the best predictor of PHT.
Results. PHT was found in 37 patients. An MPA diameter of 30 mm or greater yielded a
sensitivity, specificity, accuracy, positive, and negative predictive value of 78%, 91%, 86%,
83%, and 88%, respectively. This yielded an area under the ROC curve of 0.85.
Conclusions. MPA diameter from low-dose unenhanced multi-slice CT reliably predicts
PHT, providing an important added clinical value from AC for SPECT MPI. (J Nucl Cardiol
2011;18:634–41.)
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INTRODUCTION
Pulmonary hypertension (PHT) is an important pre-
dictor of an adverse outcome in patients with known or
suspected coronary artery disease.1 Several findings of
PHT have been reported in nuclear single-photon
emission computed tomography (SPECT) myocardial
perfusion imaging (MPI), such as flattening of the inter-
ventricular septum (D-shaped left ventricle), septal wall
motion abnormalities/perfusion defect, and right ven-
tricular (RV) enlargement or hypertrophy.2,3 Attenuation
correction (AC) of MPI with x-ray-derived attenuation
maps obtained from a single-slice computer tomography
scanner (CT) device has been introduced in the last years.4
However, transmission scans from single-slice CT scan-
ners do not allow reliable interpretation of anatomic
details. Recently, use of a high-end standalone CT scanner
has been proposed to obtain AC maps for MPI.5 These
low-dose data sets from a 64-slice scanner yield an image
quality allowing anatomic evaluation.
While contrast-enhanced chest CT scans provide
reliable signs of PHT such as enlarged main pulmonary
artery (MPA) diameter,6 expanded RV outflow tract, and
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augmented distensibility of the MPA,7 as well as
increased ratio of MPA to aortic diameter,8 the accuracy
of unenhanced low-dose CT to reliably detect PHT from
MPA diameter is not yet well validated.
The aim of this study was to identify the cut-off
MPA diameter best predicting PHT from low-dose un-
enhanced multi-slice CT for AC of MPI.
MATERIALS AND METHODS
Patients
We retrospectively screened 183 consecutive patients
referred for coronary artery disease assessment with SPECT
MPI, until 100 patients were enrolled. To compare our results
with the clinical gold standard for PHT and to have a study
population with a high prevalence of PHT we applied the
following inclusion criteria: first, transthoracic echocardiog-
raphy within 6 months from SPECT MPI, documenting the
right ventriculo-atrial (RV/RA) gradient in mm Hg. Second, a
known or suspected pulmonary pathology such as bronchial
carcinoma, dyspnea, PHT, chronic pulmonary embolism,
chronic obstructive pulmonary disease, or emphysema.
The study protocol was approved by the institutional
review board and written informed consent was obtained.
SPECT MPI Acquisition
SPECT MPI data acquisition was performed on a dual-
head detector camera (Ventri, GE Healthcare), using a 1-day
stress (0.14 mg/kg/min adenosine i.v. over 6 minutes, or
dobutamine 10-40 lg/kg/min)/rest protocol with a dose of
approximately 300 and 900 MBq of 99mTc tetrofosmin,
respectively, as previously reported.9 In brief, we acquired at
3 rotation per stop, 180 each head, and 25 s per projection,
with 16 frames per R-R cycle, according to the procedural
guidelines of the European Association of Nuclear in Medi-
cine.10 For all patients, the summed nongated SPECT image
set was reconstructed on a dedicated workstation (eNTEGRA
or Xeleris; GE Healthcare). In addition, polar maps of wall
motion (Figure 1) and perfusion (Figure 2) were produced
using a commercially available software solution (Cedars
QGS/QPS; Cedars-Sinai Medical Centre).11
SPECT MPI Interpretation
SPECT MPI interpretation was visually performed by two
nuclear cardiologists, who were blinded to the result from
echocardiography and to the CT data. For each patient the long-
and short-axis slices were visually analyzed for two findings:
flattening of the interventricular septum (D-shaped left ventri-
cle) and RV enlargement appearing as large as or greater than the
left ventricle. In addition, a quantitative analysis for RV hyper-
trophy was performed, using the peak pixel count of the RV and
LV in the original filtered back projection SPECT rest images, to
determine the RV/LV ratio as previously reported.12 A ratio
greater than 0.42 was regarded positive for RV hypertrophy
according to results in humans by Williams et al,3 based on
experimental animal data by Wackers et al.13 For quantitative
assessment of septal wall motion (Figure 1B) and perfusion
(Figure 2B) abnormality the respective QGS/QPS scores of the
six septal segments were summed.
CT Scanning
All CT scans for AC were performed on a 64-slice CT on
a LightSpeed VCT XT scanner (GE Healthcare) using pro-
spective ECG-triggering (70% of the R-R interval) and the
following scanning parameters: gantry rotation time 350 ms,
2.5 mm section thickness, 120 kV tube voltage, 200 mA
effective tube current, resulting in an estimated mean applied
radiation dose of 1.1 ± 0.1 mSv (range 0.9-1.4 mSv).14
Scanning was performed from the tracheal bifurcation to
the diaphragm, in inspiration and with elevated arms. CT
images were reconstructed at 2.5-mm slice thickness using a
reconstruction algorithm with a 512 9 512 matrix. Recon-
structed images were transferred to the external workstation for
further analysis (AW 4.4, GE Healthcare).
CT Image Analysis
Two experienced radiologists, who were blinded to the
results from echocardiography and the SPECT data, assessed the
Figure 1. A 63-year-old man with severe chronic obstructive
pneumopathy referred for cardiac risk assessment before lung
transplantation. Polar plot image of rest wall motion (A), with
corresponding semiquantitative scores (B). The QGS scores of
the six septal segments are adding up to a total score of 4.
Figure 2. Same patient as in Figure 1. Polar plot image of
stress perfusion filtered back projection image (A), with
corresponding semiquantitative scores (B). The QPS scores of
the six septal segments are adding up to a total score of 4.
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maximum MPA diameter as follows: on standard axial sections in
a soft tissue window (window width W400/level L40 Hounsfield
units) the widest diameter perpendicular to the long axis of the
MPA was measured with an electronic calliper (Figure 3). MPA
diameter was divided by the calculated body surface area
(H(weight (kg) 9 height (cm))/60) to obtain indexed values.
Echocardiography
A two-dimensional transthoracic examination was per-
formed in daily routine. The endsystolic tricuspid regurgitation
jet velocity was used to determine the right ventriculo-atrial
(RV/RA) gradient. PHT was defined as a value of 30 mm Hg
or greater, according to clinical standards. A RV/RA gradient
between 30 and 39 mm Hg was classified as mild PHT, a
gradient between 40 and 59 mm Hg as a moderate PHT and a
value of 60 mm Hg or greater as severe PHT.15
Statistical Analysis
The optimal cut-off point for predicting PHT was deter-
mined using a receiver operator characteristic (ROC) curve for
the MPA diameter and the body surface corrected MPA
diameter from unenhanced CT, for the regional scores for
septal stress perfusion defects as well as for the septal wall
motion abnormalities. For the visually analyzed MPI SPECT
signs such as D-shape and RV enlargement sensitivity, speci-
ficity, positive, and negative predictive values were calculated.
In addition, all five SPECT MPI criteria for PHT (septal stress
perfusion defects/wall motion abnormalities, RV hypertrophy/
enlargement and D-shape) and the MPA diameter were added
up to a total score (0-6). ROC analysis was performed for these
summed criteria. The optimal cut-off point for all ROC curves
was determined using the Youden index (J value), calculated
as the maximum of J = SN ? SP - 1, where SN is sensitivity
and SP is specificity, for each cut-off volume.16 Areas under
the ROC curve (AUC) were calculated and statistically
compared with the Delong Delong Clarke-Pearson method17
using STATA software (STATA 10.1, Texas, USA).
Pearson’s correlation coefficient and Bland-Altman
analysis were used to determine the inter-observer agreement
of the measured MPA diameter. A P value of \.05 was con-
sidered to indicate statistical significance. Additional
Bonferroni correction was performed, where appropriate. The
inter-observer agreement of the visual analysis for D-shaped
left ventricular deformation and enlarged right ventricle as
well as for the measured MPA diameter was determined by
kappa coefficient, with a k value of 0.2-0.4 indicating a fair
agreement, 0.41-0.6 a moderate agreement, 0.61-0.8 a sub-
stantial agreement, and 0.81-1.00 an almost perfect agreement,
according to Landis and Koch.12 SPSS software (version 18.0,
SPSS inc.) was used for statistical testing.
RESULTS
Patient Characteristics
Patient characteristics are listed in Table 1. From 100
enrolled patients with suspected or known pulmonary
pathologies, 60 were referred for preoperative coronary
artery disease assessment and in 40 patients the main
reason for cardiac SPECT MPI was dyspnea. For further
clinical information see Table 2. In 72 patients stress
examination was performed with 0.14 mg/kg/min adeno-
sine i.v. without any complications. In 28 patients dobuta-
mine stress was performed, due to known severe COPD.
In 2 patients a systemic lupus erythematosus was
present, but none of them had an aneurysmal pulmonary
artery. In 2 patients a a1-antitrypsin deficiency was
known, one had no PHT, the second patient had a mild
PHT (36 mm Hg pressure gradient) with moderate MPA
dilatation of 32 mm.
CT and MPI Results
AUC for MPA diameter as predictor of PHT was 0.85
(with a 95% confidence interval 0.724-0.923, P \ .001)
with a resulting cut-off value of 30 mm using the Youden-
Index, which yielded a sensitivity, specificity, positive
(PPV), and negative predictive value (NPV) and accuracy
of 78%, 91%, 83%, 88%, and 86%, respectively. Correc-
tion of the MPA diameter for the calculated body surface
area resulted in a slight decrease of the AUC (0.82), with a
cut-off at 1.6 cm/m2, therefore the uncorrected diameter
was used for further analysis. Uncorrected MPA diameter
cut-off at 30 mm with an AUC of 0.85 proved superior to
semiquantitative scores for septal stress perfusion (AUC
0.61, P [ .0002), wall motion abnormality (P \ .0001)
and RV hypertrophy (P = .037), although comparison of
the latter versus MPA diameter fall short of statistical sig-
nificance after correction according to Bonferroni
(Figure 4).
Figure 3. Main pulmonary artery (MPA) diameter is mea-
sured in standard axial slices in soft tissue window by
assessing the widest diameter perpendicular to the long axis
of the MPA.
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The combined score of all 6 PHT signs (SPECT and
CT) resulted in an AUC of 0.85 (0.77-0.93, P \ .001)
with a cut-off at 2 positive criteria, which yielded a
sensitivity, specificity, PPV, NPV, and accuracy of 86%,
74%, 67%, 90%, and 79%, respectively (Figure 4B).
Thus, the AUC for the combination of SPECT and CT
criteria was comparable to MPA diameter alone (0.85).
However, specificity and accuracy were superior for
MPA diameter alone (Table 3).
In 8 patients with documented mild PHT (RV/RA
gradient between 30 and 39 mm Hg) MPA diameter was
smaller than 3 cm classifying these as false negatives.
No false negative results were found in patients with
moderate or severe PHT. Only 6 patients had an RV/RA
gradient over 60 mm Hg, indicating a severe PHT. The
relationship between MPA diameter and PHT is not
linear, as it flattens off at higher RV/RA gradients
(Figure 5). Therefore, a reliable cut-off value to distin-
guish severe from non-severe PHT cannot be obtained.
The visual appreciation of the short- and long-axis
SPECT MPI images of observer one resulted in 47
patients (38 patients for observer two) with a D-shaped
left ventricular deformation. There was a moderate inter-
observer correlation with a kappa value of 0.533. 28 of
the patients with diagnosed D-shape by observer one had
a pulmonary hypertension; this resulted in a sensitivity,
specificity, positive, and negative predictive value of
76%, 70%, 60%, and 83%, respectively. Relative RV
enlargement was found only in 19 patients by observer
one and in 25 patients by observer two, what conferred in
a poor sensitivity (37%) but high specificity (92%) of
observer one, with a positive and negative predictive
value of 73% and 71%, respectively, and a slightly higher
sensitivity (38%) but lower specificity (82%) by observer
two. The inter-observer agreement was fair with a kappa
value of 0.362. An overview of all results is given in
Table 3.
Inter-observer analysis of MPA diameter assess-
ment revealed an excellent correlation between the two
observers (r = 0.94, P \ .001) with narrow Bland-Alt-
man limits of agreement (-3.1 to 3.8 mm) (Figure 6).
This resulted in a 94% agreement of PHT diagnosis.
There was no relation between a MPA diameter of
30 mm or greater and weight, height or BMI as reflected
by the area under the ROC curve (AUC) of 0.47, 0.53,
and 0.46, respectively.
Two cases are illustrated in Figures 7 and 8.
DISCUSSION
Our results suggest that unenhanced CT scans as
routinely performed for AC of SPECT MPI can be used
to reliably predict PHT, since an MPA diameter of
30 mm or greater has a high sensitivity (78%) and an
excellent specificity (91%), with a high inter-observer
agreement (r = 0.94, P \ .001). The established visual
SPECT signs are less accurate, and have a moderate
inter-observer agreement (kappa = 0.533 for D-shape
and 0.362 for left ventricular enlargement). The best
SPECT MPI finding is the RV hypertrophy, measured
with the ratio of the peak pixel count RV:LV, with good
specificity (87%) but with a poor sensitivity (41%),
when using a cut-off at 0.42.
Combining all five SPECT MPI criteria for PHT
(septal perfusion defect, septal wall motion abnormality,
Table 1. Patient demographics
Number of patients 100
Age (mean ± SD, years) 65.2 ± 11.2
Male gender 64
Weight (mean ± SD, kg) 75.6 ± 16.7
Height (mean ± SD, cm) 168.6 ± 9.5
BMI (mean ± SD, kg/m2) 26.4 ± 5.3
Time interval between SPECT/CT
and Echo (mean ± SD, months)
0.36 ± 2.5
SD, Standard deviation.
Table 2. Patient characteristics
Number of patients with pulmonary
hypertension
37
Mild PHT 19
Moderate PHT 12
Severe PHT 6
Reason for CAD assessment
Preoperative risk assessment 60
Resection of bronchial carcinoma 24
Wedge resection (other) 8
Lung transplantation 10
Liver surgery (in patients with suspected
PHT)
18
Dyspnea 40
Not further specified 35
Known PHT 3
Chronic pulmonary embolism 2
Confirmed CAD by SPECT MPI
Total number of patients with a perfusion
defect
26
Ischemia (Septal defect) 18 (3)
Scar 20
Both 12
CAD, Coronary artery disease, PHT: pulmonary hypertension.
Mild PHT: RV/RA-gradient of 30-39.9 mm Hg.
Moderate PHT: RV/RA-gradient of 40-59.9 mm Hg.
Severe PHT: RV/RA-gradient of 60 or greater mm Hg.
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D-shape, RV enlargement, and RV hypertrophy) with the
MPA diameter from CT, yields an accuracy of 79% (AUC
0.85) compared to 86% (AUC 0.85) of MPA diameter
alone.
In the only previous study in which MPA was
assessed from unenhanced CT images to evaluate PHT,
a cut-off at 33.2 mm was determined yielding a speci-
ficity similar to our study but with a much lower
Figure 4. Receiver operating characteristic (ROC) curves are obtained in A for main pulmonary
artery (MPA) diameter [red, which yields the largest area under the curve (0.85)], and for the
semiquantitative scores for septal wall motion abnormalities (dark blue), septal stress perfusion
defects (blue), and right ventricular hypertrophy (light blue). The resulting cut-off for MPA
diameter is 30 mm, yielding a sensitivity, specificity, positive, negative predictive value, and an
accuracy of 78%, 91%, 83%, 88%, and 86%, respectively. B The ROC curve for MPA diameter
(red) is compared to the ROC curve for the combined SPECT/CT score (green) (including septal
stress perfusion defect and wall motion abnormality, RV hypertrophy, D-shape and RV
enlargement, as well as the MPA diameter). The AUC for the combination of SPECT and CT
criteria as well as for the MPA alone is identical (0.85), however specificity and accuracy are still
higher for the MPA diameter.
Table 3. Predictors of PHT
Criteria
Septal
perfusion
Septal
motion
RV
hypertrophy
D-
Shape
RV
enlarged
MPA
diameter
SPECT/CT
combination
AUC 0.61* 0.59* 0.75* N/A N/A 0.85 0.85
95% CI 0.492–0.729 0.475–0.709 0.661–0.850 N/A N/A 0.724–0.923 0.768–0.931
P value .07 .131 .001 N/A N/A \.001 \.001
Cut-off 1 1 0.42 N/A N/A 30 mm 2
Sensitivity (%) 59 56 40.5 76 35 78 86
Specificity (%) 57 60 87.3 70 92 91 74
PPV (%) 45 45 65.2 60 72 83 66
NPV (%) 70 70 71.4 83 70 88 90
Accuracy (%) 58 59 70 72 71 86 79
CI, Confidence Interval.
* P\ .05, if compared with MPA diameter according to Delong Delong Clarke-Pearson.
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sensitivity (58%).18 This was probably due—at least in
part—to the fact that their slice thickness (10 mm)
allowed less accurate measurements of anatomic struc-
tures than our CT data with a slice thickness of 2.5 mm.
There is a large body of literature with contrast
enhanced CT which has established an MPA diameter
exceeding 29 mm as predictor of PHT.19 This value is
slightly below our results, because contrast-enhanced
CT provides the luminal diameter while in unenhanced
CT the distance of the outer vessel boundaries are
measured.
The unenhanced CT scan of this study was per-
formed to obtain attenuation maps for the SPECT MPI
and not primarily for diagnostic purposes. Nevertheless,
several reports on incidental findings with clinical rele-
vance have stimulated a vivid controversy on whether
a systematic readout of unenhanced CT for AC is
mandatory for medico legal and ethical aspects or del-
eterious due to low specificity generating potentially
unnecessary harms and costs of further examinations. It
is in this setting that the present results are of great
potential clinical importance as our MPA cut-off pro-
vides an excellent specificity combined with a large
AUC to predict PHT, a clinically relevant finding with
important implications for perioperative or long-term
patient care directly affecting their outcome. Therefore,
assessment of MPA diameter from unenhanced CT may
be considered as a justifiable added value to SPECT
MPI.
It may be perceived as a limitation of this study that
echocardiography and CT examinations were not per-
formed on the same day, as the pulmonary pressure may
be subject to changes over time. However, the fact that
despite this potential drawback the AUC was large
strengthens our results and may support that MPA
enlargement not only reflects acute increase in pul-
monary pressure but also represents the result of long-
term PHT. In addition, using echocardiography as gold
standard for assessing PHT may be less accurate than
Figure 5. There was no linear correlation between pulmonary
hypertension (represented by the RV/RA gradient) and MPA
diameter, evidenced by the flattening of the curve for higher
pressures. To determine a reliable cut-off to distinguish severe
from non-severe PHT is in this study population not possible.
Figure 6. Inter-observer analysis of the main pulmonary artery diameter assessed by the two
observers: Pearson correlation reveals an excellent correlation (r = 0.94, P \ .001) (A), and Bland-
Altman analysis narrow limits of agreement (mean 0.34 mm, SD 1.8 mm) (B).
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invasive right heart catheterization. However, this cor-
responds to daily clinical routine, on which commonly
decision making is based. Therefore, it appears justifi-
able to validate our CT-results against the clinical gold
standard echocardiography.
Our results show that the sensitivity of the MPA
diameter to predict PHT is not optimal (78%), suggest-
ing that unenhanced attenuation CT should not be
recommended as a first line screening tool for PHT.
Another potential limitation is that the assessment
of the RV/LV ratio in this study was assessed by use of
the average counts in the area with the highest counts,
while others have used the maximum count per pixel in
this region. However, both methods have been shown to
provide interchangeable and equally reproducible
results.12
Furthermore, the presence of collagen disorders in
some of our patients may potentially hamper the
generalization of our results, because such patients
would be prone to early MPA enlargement at pulmonary
pressures in the upper normal range. However, only in
two of our patients a a1-antitrypsin deficiency was
reported, of whom one was true positive and the other
was true negative.
In addition, the image quality of our stand-alone CT
scanner may not necessarily be matched by that obtained
in Hybrid devices with low end CT scanners.
Finally, the prevalence of pulmonary hypertension
in this study population is higher than in the general
population referred for SPECT MPI in most centers.
However, this selection appears reasonable for such a
validation study, to include a sufficient number of
patients presenting with the tested pathology, to avoid an
artificially high specificity. This would strengthen our
results when applied to low prevalence populations. The
principle of MPA diameter as a reliable predictor of
Figure 7. Same patient as in Figure 1. Echocardiography 2 weeks before SPECT MPI showed an
RA/RV gradient of 75 mm Hg. As in this case, 35% of patients with pulmonary hypertension
documented by echocardiography reveal an enlarged main pulmonary artery (A) and typical
SPECT MPI findings such as D-shaped left ventricle in axial short axis slices (B), wall motion
abnormalities (C), and perfusion defect in filtered back projection stress perfusion (D).
Figure 8. A 66-year-old woman with known chronic obstructive pneumopathy referred for cardiac
risk assessment before wedge resection. Echocardiography 5 months before SPECT MPI showed
an RA/RV gradient of 40 mm Hg. As in this case, 43% of patients with pulmonary hypertension
have an enlarged main pulmonary artery (A) but SPECT MPI signs are not conclusive or negative
[short axis slices (B), wall motion rest (C), and filtered back projection stress perfusion (D)].
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PHT has been well established for contrast-enhanced CT
in large patient cohorts. Although this study extends this
to unenhanced low-dose CT the pilot nature limits its
power. Therefore, the finding should be interpreted with
caution before data from larger studies are available.
This is particularly true given that in clinical practice the
4% patients misclassified with possible PHT would
likely be referred on having further testing such as
echocardiography.
CONCLUSION
The non-contrast-enhanced CT scan can be used to
detect PHT, while SPECT MPI parameters are less
accurate in detecting PHT. Thus, in patients undergoing
SPECT MPI with a CT attenuation scan; this measure-
ment can be reliably performed and may provide useful
information about the potential PHT without any addi-
tional scans.
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